nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Abstract
|
|
|
2012 |
|
5 |
p. 340- 1 p. |
artikel |
2 |
Acknowledgments
|
Becker, Gavin J. |
|
2012 |
|
5 |
p. 404- 1 p. |
artikel |
3 |
A Japanese approach for CKD-MBD
|
Yokoyama, Keitaro |
|
2013 |
|
5 |
p. 451-456 6 p. |
artikel |
4 |
A phosphate-centric paradigm for pathophysiology and therapy of chronic kidney disease
|
Kuro-o, Makoto |
|
2013 |
|
5 |
p. 420-426 7 p. |
artikel |
5 |
Biographic and disclosure information
|
|
|
2012 |
|
5 |
p. 398-403 6 p. |
artikel |
6 |
Calcimimetics and outcomes in CKD
|
Drüeke, Tilman B. |
|
2013 |
|
5 |
p. 431-435 5 p. |
artikel |
7 |
Chapter 6: Blood pressure management in children with CKD ND
|
|
|
2012 |
|
5 |
p. 372-376 5 p. |
artikel |
8 |
Chapter 4: Blood pressure management in CKD ND patients with diabetes mellitus
|
|
|
2012 |
|
5 |
p. 363-369 7 p. |
artikel |
9 |
Chapter 3: Blood pressure management in CKD ND patients without diabetes mellitus
|
|
|
2012 |
|
5 |
p. 357-362 6 p. |
artikel |
10 |
Chapter 7: Blood pressure management in elderly persons with CKD ND
|
|
|
2012 |
|
5 |
p. 377-381 5 p. |
artikel |
11 |
Chapter 5: Blood pressure management in kidney transplant recipients (CKD T)
|
|
|
2012 |
|
5 |
p. 370-371 2 p. |
artikel |
12 |
Chapter 8: Future directions and controversies
|
|
|
2012 |
|
5 |
p. 382-387 6 p. |
artikel |
13 |
Chapter 1: Introduction
|
|
|
2012 |
|
5 |
p. 343-346 4 p. |
artikel |
14 |
Chapter 2: Lifestyle and pharmacological treatments for lowering blood pressure in CKD ND patients
|
|
|
2012 |
|
5 |
p. 347-356 10 p. |
artikel |
15 |
Fibroblast growth factor 23 and 25-hydroxyvitamin D levels are associated with estimated glomerular filtration rate decline
|
Hamano, Takayuki |
|
2013 |
|
5 |
p. 469-475 7 p. |
artikel |
16 |
Foreword
|
Kasiske, Bertram L. |
|
2012 |
|
5 |
p. 338- 1 p. |
artikel |
17 |
Hyperphosphatemia is a combined function of high serum PTH and high dietary protein intake in dialysis patients
|
Streja, Elani |
|
2013 |
|
5 |
p. 462-468 7 p. |
artikel |
18 |
Impact of cinacalcet introduction on MBD management: the MBD-5D study in Japan
|
Fukuma, Shingo |
|
2013 |
|
5 |
p. 436-441 6 p. |
artikel |
19 |
Introduction: expanding concepts of chronic kidney disease-mineral and bone disorder (CKD-MBD)
|
Fukagawa, Masafumi |
|
2013 |
|
5 |
p. 419- 1 p. |
artikel |
20 |
Mechanisms of arterial calcifications and consequences for cardiovascular function
|
London, Gérard M. |
|
2013 |
|
5 |
p. 442-445 4 p. |
artikel |
21 |
Methods for guideline development
|
|
|
2012 |
|
5 |
p. 388-397 10 p. |
artikel |
22 |
Notice
|
|
|
2012 |
|
5 |
p. 337- 1 p. |
artikel |
23 |
Optimizing the cost-effectiveness of treatment for chronic kidney disease-mineral and bone disorder
|
Goto, Shunsuke |
|
2013 |
|
5 |
p. 457-461 5 p. |
artikel |
24 |
References
|
|
|
2012 |
|
5 |
p. 405-414 10 p. |
artikel |
25 |
Summary of Recommendation Statements
|
|
|
2012 |
|
5 |
p. 341-342 2 p. |
artikel |
26 |
Uremic osteoporosis
|
Kazama, Junichiro J. |
|
2013 |
|
5 |
p. 446-450 5 p. |
artikel |
27 |
Vitamin D receptor activation: cardiovascular and renal implications
|
Nigwekar, Sagar U. |
|
2013 |
|
5 |
p. 427-430 4 p. |
artikel |
28 |
Work Group Membership
|
|
|
2012 |
|
5 |
p. 339- 1 p. |
artikel |